Tuesday, October 17, 2017 6:20:54 PM
#2 Yes it's possible. I doubt anything will favor Momenta.
#3 Probable
#4 Inmaterial
#5 Inmaterial
#6 Inmaterial
#7 That's a good one. Every day hurts because I would see no reason that if a patient is put on Generic X there would be any reason besides price they'd switch to Generic Y
#8 Yes, went long last Friday and I'll stick with it until it hits the $16 -$17 range.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM